PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Conditions
Cancer
Interventions
BIOLOGICAL

PV701

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00055705 - PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer | Biotech Hunter | Biotech Hunter